There are 2867 resources available
Discussion
Presenter: All Speakers
Session: Insight the new CNS WHO classification: Novel concepts and therapeutic implications for gliomas
Resources:
Webcast
CN12 - Impact of diet on immune checkpoint blockade: Nurse-directed dietary intervention
Presenter: Julie Malo
Session: Health promotion, prevention, and screening
Resources:
Abstract
De-escalation from a patients’ perspective
Presenter: Tanja Spanic
Session: De-escalation of treatment in medical oncology
Resources:
Slides
Webcast
How to target invisible melanoma cells
Presenter: Caroline Robert
Session: Is heterogeneity the limitation of precision oncology in melanoma?
Resources:
Slides
Webcast
The role of KRAS inhibitor and other new treatment options in pancreatic cancer
Presenter: Eileen O'Reilly
Session: Lessons learned and new horizons and other hepatobiliary/pancreatic malignancies
Resources:
Slides
Webcast
Where does IO fit in?
Presenter: Rina Hui
Session: Slicing the pie: Advances in targeted therapy for oncogene-addicted NSCLC
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: Developmental therapeutics
Resources:
Webcast
1735O - PD-L1 expression on immune cells by SP142 co-localises with dendritic cells and is associated with improved overall survival (OS) with atezolizumab in patients with untreated metastatic urothelial cancer (mUC)
Presenter: Enrique Grande Pulido
Session: Proffered Paper session 1: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
658MO - Pembrolizumab (pembro) vs standard-of-care (SOC) in previously treated recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): 6-year follow-up of KEYNOTE-040
Presenter: Denis Soulieres
Session: Mini Oral session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
CN13 - Nutriscore: Nutritional screening in colorectal cancer patients previous to cancer-specific treatment
Presenter: Raquel Legido-Diaz
Session: Health promotion, prevention, and screening
Resources:
Abstract